Hello Heart Comparables
Find the most relevant public market comparables for Hello Heart, including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
Hello Heart is a digital therapeutics company focused on preventive heart health. They offer a connected blood pressure monitor and an AI-driven digital coaching app to help users manage and improve their cardiovascular health. The company's system provides real-time personalized tips for various conditions like diabetes, hypertension, and body weight, enabling users to self-manage hypertension, drive behavior change, and prevent serious health risks. Their solution is validated in peer-reviewed studies and shows significant reductions in blood pressure over a sustained period.
Business Model
B2B2C. They sell their software solution through self-insured employers and health plans to reach individual consumers.
Target Customers
Employers, health plans, and individuals with cardiovascular health risks.
Specific Focus
Preventive cardiovascular health management
Location
Menlo Park, California
CEO
Maayan Cohen
Industry
Life sciences
Sub Sector
Digital Therapeutics
3yr Revenue Growth
567%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Hello Heart in the Health Technology sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Hello Heart? Our platform provides detailed analysis of Hello Heart's competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Hello Heart compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Hello Heart Compset
As a leading player in the Life sciences industry within the Health Technology sector, Hello Heart operates in the specialized Digital Therapeutics sub-sector. Understanding how Hello Heart compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Digital Therapeutics space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
TG Therapeutics, Inc.
Healthcare • Life sciences
TG Therapeutics, Inc. is a fully integrated, commercial-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. They have received FDA approval for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis.
Vytalize Health
Healthcare • Life sciences
Vytalize Health is a risk-bearing provider enablement platform and leading Accountable Care Organization (ACO) that partners with primary care physicians (PCPs) to deliver value-based care, improving patient outcomes and reducing healthcare costs. They offer an all-in-one solution including value-based incentives, smart technology, and a virtual clinic, enabling independent practices to thrive in value-based care arrangements. The company focuses on Medicare patients and works with over 2,500 PCPs across 36 states.
Talkiatry
Healthcare • Life sciences
Talkiatry is a national mental health practice providing in-network psychiatry and therapy via telehealth. It utilizes technology and a human-centered approach to improve access to high-quality mental healthcare, addressing issues of accessibility and affordability.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Hello Heart and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free